Altered Expression of Astrocyte-Related Receptors and Channels Correlates With Epileptogenesis in Hippocampal Sclerosis
2019; SAGE Publishing; Volume: 22; Issue: 6 Linguagem: Inglês
10.1177/1093526619855488
ISSN1615-5742
AutoresYoshinori Aoki, Sae Hanai, Sayuri Sukigara, Taisuke Otsuki, Takashi Saito, Eiji Nakagawa, Takanobu Kaido, Yuu Kaneko, Akihisa Takahashi, Naoki Ikegaya, Masaki Iwasaki, Kenji Sugai, Masayuki Sasaki, Yu‐ichi Goto, Akira Oka, Masayuki Itoh,
Tópico(s)Epilepsy research and treatment
ResumoBackground Hippocampal sclerosis (HS) is one of the major causes of intractable epilepsy. Astrogliosis in epileptic brain is a peculiar condition showing epileptogenesis and is thought to be different from the other pathological conditions. The aim of this study is to investigate the altered expression of astrocytic receptors, which contribute to neurotransmission in the synapse, and channels in HS lesions. Methods We performed immunohistochemical and immunoblotting analyses of the P2RY1, P2RY2, P2RY4, Kir4.1, Kv4.2, mGluR1, and mGluR5 receptors and channels with the brain samples of 20 HS patients and 4 controls and evaluated the ratio of immunopositive cells and those expression levels. Results The ratio of each immunopositive cell per glial fibrillary acidic protein-positive astrocytes and the expression levels of all 7 astrocytic receptors and channels in HS lesions were significantly increased. We previously described unique astrogliosis in epileptic lesions similar to what was observed in this study. Conclusion This phenomenon is considered to trigger activation of the related signaling pathways and then contribute to epileptogenesis. Thus, astrocytes in epileptic lesion may show self-hyperexcitability and contribute to epileptogenesis through the endogenous astrocytic receptors and channels. These findings may suggest novel astrocytic receptor-related targets for the pharmacological treatment of epilepsy.
Referência(s)